Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-17 Purchase |
2021-02-17 6:05 pm |
Codiak BioSciences Inc. | CDAK | Morrison Briggs Director |
4,761 | $21 | $99,981 | 4,761 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-10 4:23 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
35,156 | $20.55 | $722,403 | 48,336 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-12 5:55 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
80,404 | $20.04 | $1,611,577 | 46,565 (Direct) |
View |
| 2020-06-23 Purchase |
2020-06-25 5:57 pm |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
4,800 | $20 | $96,000 | 4,800 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-08 Exercise |
2021-02-10 4:23 pm |
N/A 2025-06-30 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
35,156 | $0 | 48,336 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 4:23 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
35,156 | $7.2 | 48,336 (Direct) |
View |
| 2021-01-31 Other |
2021-02-05 4:21 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
1,771 | $12 | 245,107 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:21 pm |
N/A 2031-02-03 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
195,000 | $0 | 245,107 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:55 pm |
N/A 2025-06-01 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
80,404 | $0 | 46,565 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:55 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
80,404 | $7.2 | 46,565 (Direct) |
View |
| 2020-10-13 Option Award |
2020-10-15 8:10 pm |
N/A 2030-10-12 |
Codiak BioSciences Inc. | CDAK | Morrison Briggs Director |
10,000 | $0 | 10,000 (Direct) |
View |
Ownership |
2020-10-13 9:21 pm |
N/A 2028-03-28 |
Codiak BioSciences Inc. | CDAK | Morrison Briggs Director |
0 | $0 | 28,783 (Direct) |
View |
Ownership |
2020-10-01 7:13 pm |
N/A 2026-04-26 |
Oncorus Inc. | ONCR | Morrison Briggs Director |
0 | $0 | 32,846 (Direct) |
View |
Ownership |
2020-06-18 9:32 pm |
N/A 2027-06-22 |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
0 | $0 | 90,728 (Direct) |
View |